Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Impaired neurovascular coupling in aging and Alzheimer's disease: Contribution of astrocyte dysfunction and endothelial impairment to cognitive decline.

Tarantini S, Tran CHT, Gordon GR, Ungvari Z, Csiszar A.

Exp Gerontol. 2017 Aug;94:52-58. doi: 10.1016/j.exger.2016.11.004. Epub 2016 Nov 12. Review.

PMID:
27845201
2.

Requisite ischemia for spreading depolarization occurrence after subarachnoid hemorrhage in rodents.

Oka F, Hoffmann U, Lee JH, Shin HK, Chung DY, Yuzawa I, Chen SP, Atalay YB, Nozari A, Hopson KP, Qin T, Ayata C.

J Cereb Blood Flow Metab. 2017 May;37(5):1829-1840. doi: 10.1177/0271678X16659303. Epub 2016 Jan 1.

PMID:
27432225
3.

Cell type specificity of neurovascular coupling in cerebral cortex.

Uhlirova H, Kılıç K, Tian P, Thunemann M, Desjardins M, Saisan PA, Sakadžić S, Ness TV, Mateo C, Cheng Q, Weldy KL, Razoux F, Vandenberghe M, Cremonesi JA, Ferri CG, Nizar K, Sridhar VB, Steed TC, Abashin M, Fainman Y, Masliah E, Djurovic S, Andreassen OA, Silva GA, Boas DA, Kleinfeld D, Buxton RB, Einevoll GT, Dale AM, Devor A.

Elife. 2016 May 31;5. pii: e14315. doi: 10.7554/eLife.14315.

4.

Longitudinal decrease in blood oxygenation level dependent response in cerebral amyloid angiopathy.

Switzer AR, McCreary C, Batool S, Stafford RB, Frayne R, Goodyear BG, Smith EE.

Neuroimage Clin. 2016 Mar 3;11:461-7. doi: 10.1016/j.nicl.2016.02.020. eCollection 2016.

5.

Microvascular Dysfunction and Cognitive Impairment.

De Silva TM, Faraci FM.

Cell Mol Neurobiol. 2016 Mar;36(2):241-58. doi: 10.1007/s10571-015-0308-1. Epub 2016 Mar 17. Review.

6.

Differential pathlength factor informs evoked stimulus response in a mouse model of Alzheimer's disease.

Lin AJ, Ponticorvo A, Durkin AJ, Venugopalan V, Choi B, Tromberg BJ.

Neurophotonics. 2015 Oct;2(4):045001. doi: 10.1117/1.NPh.2.4.045001. Epub 2015 Oct 12.

7.

Heparan sulfate proteoglycans mediate Aβ-induced oxidative stress and hypercontractility in cultured vascular smooth muscle cells.

Reynolds MR, Singh I, Azad TD, Holmes BB, Verghese PB, Dietrich HH, Diamond M, Bu G, Han BH, Zipfel GJ.

Mol Neurodegener. 2016 Jan 22;11:9. doi: 10.1186/s13024-016-0073-8.

8.

Cerebrovascular disease in ageing and Alzheimer's disease.

Love S, Miners JS.

Acta Neuropathol. 2016 May;131(5):645-58. doi: 10.1007/s00401-015-1522-0. Epub 2015 Dec 28. Review.

9.

Vascular cognitive impairment and dementia.

Gorelick PB, Counts SE, Nyenhuis D.

Biochim Biophys Acta. 2016 May;1862(5):860-8. doi: 10.1016/j.bbadis.2015.12.015. Epub 2015 Dec 15.

10.

Pathophysiology of Hypoperfusion of the Precuneus in Early Alzheimer's Disease.

Miners JS, Palmer JC, Love S.

Brain Pathol. 2016 Jul;26(4):533-41. doi: 10.1111/bpa.12331. Epub 2015 Nov 9.

11.

Spreading Depression, Spreading Depolarizations, and the Cerebral Vasculature.

Ayata C, Lauritzen M.

Physiol Rev. 2015 Jul;95(3):953-93. doi: 10.1152/physrev.00027.2014. Review.

12.

Glio-vascular changes during ageing in wild-type and Alzheimer's disease-like APP/PS1 mice.

Janota CS, Brites D, Lemere CA, Brito MA.

Brain Res. 2015 Sep 16;1620:153-68. doi: 10.1016/j.brainres.2015.04.056. Epub 2015 May 9.

13.

Ischemic brain injury in cerebral amyloid angiopathy.

Reijmer YD, van Veluw SJ, Greenberg SM.

J Cereb Blood Flow Metab. 2016 Jan;36(1):40-54. Review.

14.

Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice.

Han BH, Zhou ML, Johnson AW, Singh I, Liao F, Vellimana AK, Nelson JW, Milner E, Cirrito JR, Basak J, Yoo M, Dietrich HH, Holtzman DM, Zipfel GJ.

Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):E881-90. doi: 10.1073/pnas.1414930112. Epub 2015 Feb 9.

15.

Increased cerebral vascular reactivity in the tau expressing rTg4510 mouse: evidence against the role of tau pathology to impair vascular health in Alzheimer's disease.

Wells JA, Holmes HE, O'Callaghan JM, Colgan N, Ismail O, Fisher EM, Siow B, Murray TK, Schwarz AJ, O'Neill MJ, Collins EC, Lythgoe MF.

J Cereb Blood Flow Metab. 2015 Mar;35(3):359-62. doi: 10.1038/jcbfm.2014.224. Epub 2014 Dec 17.

16.

The Cerebrovascular Basement Membrane: Role in the Clearance of β-amyloid and Cerebral Amyloid Angiopathy.

Morris AW, Carare RO, Schreiber S, Hawkes CA.

Front Aging Neurosci. 2014 Sep 19;6:251. doi: 10.3389/fnagi.2014.00251. eCollection 2014. Review.

17.

Cerebral amyloid angiopathy increases susceptibility to infarction after focal cerebral ischemia in Tg2576 mice.

Milner E, Zhou ML, Johnson AW, Vellimana AK, Greenberg JK, Holtzman DM, Han BH, Zipfel GJ.

Stroke. 2014 Oct;45(10):3064-9. doi: 10.1161/STROKEAHA.114.006078. Epub 2014 Sep 4.

18.

Optical imaging in an Alzheimer's mouse model reveals amyloid-β-dependent vascular impairment.

Lin AJ, Liu G, Castello NA, Yeh JJ, Rahimian R, Lee G, Tsay V, Durkin AJ, Choi B, LaFerla FM, Chen Z, Green KN, Tromberg BJ.

Neurophotonics. 2014 Jul;1(1):011005.

19.

Current pathophysiological concepts in cerebral small vessel disease.

Rincon F, Wright CB.

Front Aging Neurosci. 2014 Mar 24;6:24. doi: 10.3389/fnagi.2014.00024. eCollection 2014. Review.

20.

Impact of age on the cerebrovascular proteomes of wild-type and Tg-SwDI mice.

Searcy JL, Le Bihan T, Salvadores N, McCulloch J, Horsburgh K.

PLoS One. 2014 Feb 26;9(2):e89970. doi: 10.1371/journal.pone.0089970. eCollection 2014.

Supplemental Content

Support Center